Smith‐Lemli‐Opitz Syndrome and the DHCR7 Gene

2003/05/01 by Petr Jira, P. E. Jira, H. R. Waterham +7 · 20 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Cholesterol and Lipid Metabolism #Cancer, Lipids, and Metabolism #Lipid metabolism and biosynthesis

paper · doi:10.1046/j.1469-1809.2003.00034.x

Abstract

Smith-Lemli-Opitz syndrome, a severe developmental disorder associated with multiple congenital anomalies, is caused by a defect of cholesterol biosynthesis. Low cholesterol and high concentrations of its direct precursor, 7-dehydrocholesterol, in plasma and tissues are the diagnostic biochemical hallmarks of the syndrome. The plasma sterol concentrations correlate with severity and disease outcome. Mutations in the DHCR7 gene lead to deficient activity of 7-dehydrocholesterol reductase (DHCR7), the final enzyme of the cholesterol biosynthetic pathway. The human DHCR7 gene is localised on chromosome 11q13 and its structure has been characterized. Ninety-one different mutations in the DHCR7 gene have been published to date. This paper is a review of the clinical, biochemical and molecular genetic aspects.

Cited by

• Retinal degeneration in a rodent model of Smith-Lemli-Opitz syndrome: electrophysiologic, biochemical, and morphologic features. [europepmc]
• The role of cholesterol in rod outer segment membranes. [europepmc]
• Lipid hydroperoxide formation in the retina: correlation with retinal degeneration and light damage in a rat model of Smith-Lemli-Opitz syndrome. [europepmc]
• Light-induced exacerbation of retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome. [europepmc]
• Lipid rafts, cholesterol, and the brain. [europepmc]
• Molecular consequences of altered neuronal cholesterol biosynthesis. [europepmc]
• Developing a Predictive Gene Classifier for Autism Spectrum Disorders Based upon Differential Gene Expression Profiles of Phenotypic Subgroups. [europepmc]
• HFE gene variants, iron, and lipids: a novel connection in Alzheimer's disease. [europepmc]
• Hedgehog signaling and steroidogenesis. [europepmc]
• Investigation of 7-dehydrocholesterol reductase pathway to elucidate off-target prenatal effects of pharmaceuticals: a systematic review. [europepmc]
• Maternal aripiprazole exposure interacts with 7-dehydrocholesterol reductase mutations and alters embryonic neurodevelopment. [europepmc]
• Dexamethasone Predisposes Human Erythroblasts Toward Impaired Lipid Metabolism and Renders Their ex vivo Expansion Highly Dependent on Plasma Lipoproteins. [europepmc]
• No Dataset Left Behind: Mechanistic Insights into Thyroid Receptor Signaling Through Transcriptomic Consensome Meta-Analysis. [europepmc]
• Cholesterol Deficiency Causes Impaired Osmotic Stability of Cultured Red Blood Cells. [europepmc]
• Smith-Lemli-Opitz syndrome: what is the actual risk for couples carriers of the DHCR7:c.964-1G>C variant? [europepmc]
• Congenital Anomalies of the Kidney and Urinary Tract: A Clinical Review. [europepmc]
• Sterol and oxysterol synthases near the ciliary base activate the Hedgehog pathway. [europepmc]
• Smith-Lemli-Opitz Syndrome with Biallelic c.1295A>G (p.Tyr432Cys) Variant in the DHCR7 Gene in a 73-Year-Old Woman: Report of the Oldest Patient. [europepmc]
• DHCR7: from sterol biosynthesis to oncogenic role in colorectal cancer. [europepmc]
• Temporal transcriptomic changes during neurodevelopment in a mouse model of Smith-Lemli-Opitz syndrome. [europepmc]

Related

• Le syndrome de Smith-Lemli-Opitz:aspects cliniques et biochimiques chez un nourrisson Tunisien
• Genetic and molecular architecture of familial hypercholesterolemia
• Genetic Determinants of the Familial Hypercholesterolaemia Phenotype
• Sterol biosynthesis, brain development, and disease
• THE LDL RECEPTOR LOCUS IN FAMILIAL HYPERCHOLESTEROLEMIA: Mutational Analysis of a Membrane Protein